Literature DB >> 15044751

Complete genome sequence of the apicomplexan, Cryptosporidium parvum.

Mitchell S Abrahamsen1, Thomas J Templeton, Shinichiro Enomoto, Juan E Abrahante, Guan Zhu, Cheryl A Lancto, Mingqi Deng, Chang Liu, Giovanni Widmer, Saul Tzipori, Gregory A Buck, Ping Xu, Alan T Bankier, Paul H Dear, Bernard A Konfortov, Helen F Spriggs, Lakshminarayan Iyer, Vivek Anantharaman, L Aravind, Vivek Kapur.   

Abstract

The apicomplexan Cryptosporidium parvum is an intestinal parasite that affects healthy humans and animals, and causes an unrelenting infection in immunocompromised individuals such as AIDS patients. We report the complete genome sequence of C. parvum, type II isolate. Genome analysis identifies extremely streamlined metabolic pathways and a reliance on the host for nutrients. In contrast to Plasmodium and Toxoplasma, the parasite lacks an apicoplast and its genome, and possesses a degenerate mitochondrion that has lost its genome. Several novel classes of cell-surface and secreted proteins with a potential role in host interactions and pathogenesis were also detected. Elucidation of the core metabolism, including enzymes with high similarities to bacterial and plant counterparts, opens new avenues for drug development.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15044751     DOI: 10.1126/science.1094786

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  345 in total

Review 1.  Mitochondria and trypanosomatids: targets and drugs.

Authors:  Lianet Monzote Fidalgo; Lars Gille
Journal:  Pharm Res       Date:  2011-09-21       Impact factor: 4.200

Review 2.  The antibiotic potential of prokaryotic IMP dehydrogenase inhibitors.

Authors:  L Hedstrom; G Liechti; J B Goldberg; D R Gollapalli
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

3.  Comparative analysis of apicomplexa and genomic diversity in eukaryotes.

Authors:  Thomas J Templeton; Lakshminarayan M Iyer; Vivek Anantharaman; Shinichiro Enomoto; Juan E Abrahante; G M Subramanian; Stephen L Hoffman; Mitchell S Abrahamsen; L Aravind
Journal:  Genome Res       Date:  2004-09       Impact factor: 9.043

4.  The state of research for AIDS-associated opportunistic infections and the importance of sustaining smaller research communities.

Authors:  Anthony P Sinai; Edna S Kaneshiro; Honorine Ward; Louis M Weiss; Melanie T Cushion
Journal:  Eukaryot Cell       Date:  2011-12-09

5.  Isolation and amplification of mRNA within a simple microfluidic lab on a chip.

Authors:  Sarah J Reinholt; Arne Behrent; Cassandra Greene; Ayten Kalfe; Antje J Baeumner
Journal:  Anal Chem       Date:  2013-12-13       Impact factor: 6.986

6.  Inhibition and structure of Toxoplasma gondii purine nucleoside phosphorylase.

Authors:  Teraya M Donaldson; María B Cassera; Meng-Chiao Ho; Chenyang Zhan; Emilio F Merino; Gary B Evans; Peter C Tyler; Steven C Almo; Vern L Schramm; Kami Kim
Journal:  Eukaryot Cell       Date:  2014-02-28

7.  Drug repurposing screen reveals FDA-approved inhibitors of human HMG-CoA reductase and isoprenoid synthesis that block Cryptosporidium parvum growth.

Authors:  Kovi Bessoff; Adam Sateriale; K Kyungae Lee; Christopher D Huston
Journal:  Antimicrob Agents Chemother       Date:  2013-02-04       Impact factor: 5.191

8.  Induction of Inflammatory Responses in Splenocytes by Exosomes Released from Intestinal Epithelial Cells following Cryptosporidium parvum Infection.

Authors:  Yang Wang; Yujuan Shen; Hua Liu; Jianhai Yin; Xin-Tian Zhang; Ai-Yu Gong; Xiqiang Chen; Siyi Chen; Nicholas W Mathy; Jianping Cao; Xian-Ming Chen
Journal:  Infect Immun       Date:  2019-03-25       Impact factor: 3.441

9.  Frataxin, a conserved mitochondrial protein, in the hydrogenosome of Trichomonas vaginalis.

Authors:  Pavel Dolezal; Andrew Dancis; Emmanuel Lesuisse; Róbert Sutak; Ivan Hrdý; T Martin Embley; Jan Tachezy
Journal:  Eukaryot Cell       Date:  2007-06-15

10.  Phthalazinone inhibitors of inosine-5'-monophosphate dehydrogenase from Cryptosporidium parvum.

Authors:  Corey R Johnson; Suresh Kumar Gorla; Mandapati Kavitha; Minjia Zhang; Xiaoping Liu; Boris Striepen; Jan R Mead; Gregory D Cuny; Lizbeth Hedstrom
Journal:  Bioorg Med Chem Lett       Date:  2012-12-27       Impact factor: 2.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.